Preparation and performance of porous hydroxyapatite/poly(lactic-co-glycolic acid) drug-loaded microsphere scaffolds for gentamicin sulfate delivery
Source abstract
Abstract
The prevention/treatment of osteomyelitis infection by combining the local antibiotic delivery system with the bone regeneration scaffold can effectively overcome the drawbacks of systemic antibiotic administration and realize the full cycle control of drug release. Herein, by introducing sodium carboxymethyl cellulose (SCMC) cross-linking agent to improve the binding force of poly(lactic-co-glycolic acid) (PLGA) microspheres and porous hydroxyapatite (HAp) bone scaffold. The porous HAp/PLGA drug-loaded microsphere bone scaffold for gentamicin sulfate (GS) delivery was successfully prepared. The optimal preparation parameters, drug release characteristics, SCMC enhancement mechanism, antibacterial properties and bone cell activity of porous HAp/PLGA drug-loaded microsphere bone scaffolds were comprehensively investigated. The results showed that the 0.1% SCMC-modified porous HAp/PLGA drug-loaded microsphere bone scaffold has a cumulative drug release of 45.0 ± 0.90% on the first day, which is about 20% lower than that of pure PLGA drug-loaded microspheres. Moreover, its drug release can be sustained and stably released for more than 17 d, which is attributed to the enhancement of the binding force between the microspheres and HAp by SCMC (combination for more than 3 weeks). Meanwhile, the diameter of the antibacterial ring expanded from the initial 10 ± 0.50 to 28 ± 1.2 mm after 14 d, which also indicated the sustained and stable release of GS. Alamar Blue analysis results showed that 0.1% SCMC-modified composite bone scaffold is beneficial to the proliferation activity of bone cells, and its 14 day activity increased by 20%. The above results indicate that the SCMC-modified composite bone scaffold has the potential to treat/prevent osteomyelitis.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Orthopedic Infections and Treatments · Orthopaedic implants and arthroplasty · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. Muthukrishnan G, Masters EA, Daiss JL, Schwarz EM (2019) Mechanisms of immune evasion and bone tissue colonization that make S. aureus the primary pathogen in osteomyelitis. Curr Osteoporos Rep 17:395–404. https://doi.org/10.1007/s11914-019-00548-410.1007/s11914-019-00548-4 ↗
2. Zhang J, Wei Q, Zhou H et al (2020) Sustainable release of vancomycin from micro-arc oxidised 3D-printed porous Ti6Al4V for treating methicillin-resistant S. aureus bone infection and enhancing osteogenesis in a rabbit tibia osteomyelitis model. Biomater Sci 8:3106–3115. https://doi.org/10.1039/C9BM01968E10.1039/C9BM01968E ↗
3. Mestres G, Fernandez-Yague MA, Pastorino D, Montufar EB, Canal C, Manzanares-Céspedes MC, Ginebra MP (2019) In vivo efficiency of antimicrobial inorganic bone grafts in osteomyelitis treatments. Mater Sci Eng C 97:84–95. https://doi.org/10.1016/j.msec.2018.11.06410.1016/j.msec.2018.11.064 ↗
4. Diefenbeck M, Schrader C, Gras F et al (2016) Gentamicin coating of plasma chemical oxidized titanium alloy prevents implant-related osteomyelitis in rats. Biomaterials 101:156–164. https://doi.org/10.1016/j.biomaterials.2016.05.03910.1016/j.biomaterials.2016.05.039 ↗
5. Ryan EJ, Ryan AJ, González-Vázquez A et al (2019) Collagen scaffolds functionalised with copper-eluting bioactive glass reduce infection and enhance osteogenesis and angiogenesis both in vitro and in vivo. Biomaterials 197:405–416. https://doi.org/10.1016/j.biomaterials.2019.01.03110.1016/j.biomaterials.2019.01.031 ↗
6. Dhal C, Mishra R (2020) In vitro and in vivo evaluation of gentamicin sulphate-loaded PLGA nanoparticle-based film for the treatment of surgical site infection. Drug Deliv Transl Res 10:1032–1043. https://doi.org/10.1007/s13346-020-00730-710.1007/s13346-020-00730-7 ↗
7. Dorati R, DeTrizio A, Genta I, Grisoli P, Merelli A, Tomasi C, Conti B (2016) An experimental design approach to the preparation of pegylated polylactide-co-glicolide gentamicin loaded microparticles for local antibiotic delivery. Mater Sci Eng C 58:909–917. https://doi.org/10.1016/j.msec.2015.09.05310.1016/j.msec.2015.09.053 ↗
8. McKinney W, Yonovitz A, Smolensky MH (2015) Circadian variation of gentamicin toxicity in rats. Laryngoscope 125:252–256. https://doi.org/10.1002/lary.2511610.1002/lary.25116 ↗
9. Hahn H, Salt AN, Schumacher U, Plontke SK (2013) Gentamicin concentration gradients in scala tympani perilymph following systemic applications. Audiol Neurotol 18:383–391. https://doi.org/10.1159/00035528310.1159/000355283 ↗
10. Nandi SK, Bandyopadhyay S, Das P, Samanta I, Mukherjee P, Roy S, Kundu B (2016) Understanding osteomyelitis and its treatment through local drug delivery system. Biotechnol Adv 34:1305–1317. https://doi.org/10.1016/j.biotechadv.2016.09.00510.1016/j.biotechadv.2016.09.005 ↗
11. Ji K, Wang YN, Wei QH, Zhang K, Jiang AG, Rao YW, Cai XX (2018) Application of 3D printing technology in bone tissue engineering. Bio-Design Manuf 1:203–210. https://doi.org/10.1007/s42242-018-0021-210.1007/s42242-018-0021-2 ↗
12. Kim H-W, Kim Y-J (2021) Fabrication of strontium-substituted hydroxyapatite scaffolds using 3D printing for enhanced bone regeneration. J Mater Sci 56:1673–1684. https://doi.org/10.1007/s10853-020-05391-y10.1007/s10853-020-05391-y ↗
13. Loca D, Sokolova M, Locs J, Smirnova A, Irbe Z (2015) Calcium phosphate bone cements for local vancomycin delivery. Mater Sci Eng C 49:106–113. https://doi.org/10.1016/j.msec.2014.12.07510.1016/j.msec.2014.12.075 ↗
14. Vorndran E, Geffers M, Ewald A, Lemm M, Gbureck U (2013) Ready-to-use injectable calcium phosphate bone cement paste as drug carrier. Acta Biomater 9:9558–9567. https://doi.org/10.1016/j.actbio.2013.08.00910.1016/j.actbio.2013.08.009 ↗
15. Porta GD, Campardelli R, Cricchio V, Oliva F, Maffulli N, Reverchon E (2016) Injectable PLGA/Hydroxyapatite/Chitosan microcapsules produced by supercritical emulsion extraction technology: an in vitro study on teriparatide/gentamicin controlled release. J Pharm Sci 105:2164–2172. https://doi.org/10.1016/j.xphs.2016.05.00210.1016/j.xphs.2016.05.002 ↗
16. Hamid ZAA, Tham CY, Ahmad Z (2018) Preparation and optimization of surface engineered poly(lactic acid) microspheres as a drug delivery device. J Mater Sci 53:4745–4758. https://doi.org/10.1007/s10853-017-1840-910.1007/s10853-017-1840-9 ↗
17. Bharadwaz A, Jayasuriya AC, Ambalangodage C (2020) Recent trends in the application of widely used natural and synthetic polymer nanocomposites in bone tissue regeneration. Mater Sci Eng C 110:110698. https://doi.org/10.1016/j.msec.2020.11069810.1016/j.msec.2020.110698 ↗
18. Inzana JA, Schwarz EM, Kates SL, Awad HA (2016) Biomaterials approaches to treating implant-associated osteomyelitis. Biomaterials 81:58–71. https://doi.org/10.1016/j.biomaterials.2015.12.01210.1016/j.biomaterials.2015.12.012 ↗
19. Hu X, Shen H, Yang F, Liang XJ, Wang SG, Wu DC (2014) Modified composite microspheres of hydroxyapatite and poly(lactide-co-glycolide) as an injectable scaffold. Appl Surf Sci 292:764–772. https://doi.org/10.1016/j.apsusc.2013.12.04510.1016/j.apsusc.2013.12.045 ↗
20. Son JS, Appleford M, Ong JL, Wenke JC, Kim JM, Choi SH, Oh DS (2011) Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres. J Control Release 153:133–14010.1016/j.jconrel.2011.03.010 ↗
21. Granado S, Cervera L, Kamen AA, Godia F (2018) Advancements in mammalian cell transient gene expression (TGE) technology for accelerated production of biologics. Crit Rev Biotechnol 38:918–940. https://doi.org/10.1080/07388551.2017.141945910.1080/07388551.2017.1419459 ↗
22. Lan WT, He L, Liu YW (2018) Preparation and properties of sodium carboxymethyl cellulose/sodium alginate/chitosan composite film. Coatings 8:291. https://doi.org/10.3390/coatings808029110.3390/coatings8080291 ↗
23. Qi P, Ohba S, Hara YC, Fuke M, Ogawa T, Ohta S, Ito T (2018) Fabrication of calcium phosphate-loaded carboxymethyl cellulose non-woven sheets for bone regeneration. Carbohyd Polym 189:322–330. https://doi.org/10.1016/j.carbpol.2018.02.05010.1016/j.carbpol.2018.02.050 ↗
24. Chittasupho C, Thongnopkoon T, Kewsuwan P (2016) Surface modification of poly(D, L-lactic-co-glycolic acid) nanoparticles using sodium carboxymethyl cellulose as colloidal stabilizer. Curr Drug Deliv 13:95–104. https://doi.org/10.2174/156720181266615090414424110.2174/1567201812666150904144241 ↗
25. Locs J, Zalite V, Berzina-Cimdina L, Sokolova M (2013) Ammonium hydrogen carbonate provided viscous slurry foaming—A novel technology for the preparation of porous ceramics. J Eur Ceram Soc 33:3437–3443. https://doi.org/10.1016/j.jeurceramsoc.2013.06.01010.1016/j.jeurceramsoc.2013.06.010 ↗
26. Irbe Z, Loca D, Vempere D, Berzina-Cimdina L (2012) Controlled release of local anesthetic from calcium phosphate bone cements. Mater Sci Eng 32:1690–1694. https://doi.org/10.1016/j.msec.2012.04.06910.1016/j.msec.2012.04.069 ↗
27. Mao S, Xu J, Cai CF, Germershaus O, Schaper A, Kissel T (2007) Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int J Pharmaceut 334:137–148. https://doi.org/10.1016/j.ijpharm.2006.10.03610.1016/j.ijpharm.2006.10.036 ↗
28. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Preat V (2012) PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 161:505–522. https://doi.org/10.1016/j.jconrel.2012.01.04310.1016/j.jconrel.2012.01.043 ↗
29. Chaisri W, Ghassemi AH, Hennink WE, Okonogi S (2011) Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters. Colloid Surface B 84:508–514. https://doi.org/10.1016/j.colsurfb.2011.02.00610.1016/j.colsurfb.2011.02.006 ↗
30. Ramazani F, Chen WL, van Nostrum CF, Storm G, Kiessling F, Lammers T, Hennink WE, Kok RJ (2016) Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: state-of-the-art and challenges. Int J Pharmaceut 499:358–367. https://doi.org/10.1016/j.ijpharm.2016.01.02010.1016/j.ijpharm.2016.01.020 ↗
31. Sun S, Lin J, Zhang P, Fang L, Ma R, Quan ZG, Song X (2018) Geopolymer synthetized from sludge residue pretreated by the wet alkalinizing method: compressive strength and immobilization efficiency of heavy metal. Constr Build Mater 170:619–626. https://doi.org/10.1016/j.conbuildmat.2018.03.06810.1016/j.conbuildmat.2018.03.068 ↗
32. Dhal C, Mishra R (2019) Formulation development and in vitro evaluation of gentamicin sulfate-loaded PLGA nanoparticles based film for the treatment of surgical site infection by Box-Behnken design. Drug Dev Ind Pharm 45:805–818. https://doi.org/10.1080/03639045.2019.157671910.1080/03639045.2019.1576719 ↗
33. Cheng XK, He QJ, Li JQ, Huang ZL, Chi RA (2009) Control of pore size of the bubble-template porous carbonated hydroxyapatite microsphere by adjustable pressure. Cryst Growth Des 29:2770–2775. https://doi.org/10.1021/cg801421a10.1021/cg801421a ↗
34. Flores C, Degoutin S, Chai F et al (2016) Gentamicin-loaded poly(lactic-co-glycolic acid) microparticles for the prevention of maxillofacial and orthopedic implant infections. Mater Sci Eng C 64:108–116. https://doi.org/10.1016/j.msec.2016.03.06410.1016/j.msec.2016.03.064 ↗
35. Van HN, Vu NH, Pham VH, Huan PV, Hoan BT, Nguyen DH, Manh TL (2020) A novel upconversion emission material based on Er3+–Yb3+–Mo6+ tridoped hydroxyapatite/tricalcium phosphate (HA/β-TCP). J Alloy Compd 827:154288. https://doi.org/10.1016/j.jallcom.2020.15428810.1016/j.jallcom.2020.154288 ↗
36. Zhu TT, Cui YT, Zhang MG, Zhao DY, Liu GY, Ding JX (2020) Engineered three-dimensional scaffolds for enhanced bone regeneration in osteonecrosis. Bioact Mater 5:584–601. https://doi.org/10.1016/j.bioactmat.2020.04.00810.1016/j.bioactmat.2020.04.008 ↗
37. Farhangdoust S, Zamanian A, Yasaei M, Khorami M (2013) The effect of processing parameters and solid concentration on the mechanical and microstructural properties of freeze-casted macroporous hydroxyapatite scaffolds. Mater Sci Eng C 33:453–460. https://doi.org/10.1016/j.msec.2012.09.01310.1016/j.msec.2012.09.013 ↗
38. Cui LG, Zhang J, Zou J et al (2020) Electroactive composite scaffold with locally expressed osteoinductive factor for synergistic bone repair upon electrical stimulation. Biomaterials 230:119617. https://doi.org/10.1016/j.biomaterials.2019.11961710.1016/j.biomaterials.2019.119617 ↗
39. Lai YX, Cao HJ, Wang XL et al (2018) Porous composite scaffold incorporating osteogenic phytomolecule icariin for promoting skeletal regeneration in challenging osteonecrotic bone in rabbits. Biomaterials 153:1–13. https://doi.org/10.1016/j.biomaterials.2017.10.02510.1016/j.biomaterials.2017.10.025 ↗
40. Wu CT, Ramaswamy Y, Zreiqat H (2010) Porous diopside (CaMgSi2O6) scaffold: a promising bioactive material for bone tissue engineering. Acta Biomater 6:2237–2245. https://doi.org/10.1016/j.actbio.2009.12.02210.1016/j.actbio.2009.12.022 ↗
41. Zhao XY, Han Y, Zhu TT et al (2019) Electrospun polylactide-nano-hydroxyapatite-vancomycin composite scaffolds for advanced osteomyelitis therapy. J Biomed Nanotechnol 15:1213–1222. https://doi.org/10.1166/jbn.2019.277310.1166/jbn.2019.2773 ↗
42. Li SQ, Dong SJ, Xu WG, Tu SC, Yan LS, Zhao CW, Ding JX, Chen XS (2018) Antibacterial Hydrogels. Adv Sci 5:1700527. https://doi.org/10.1002/advs.20170052710.1002/advs.201700527 ↗
43. Dulon D, Aurousseau C, Erre JP, Aran JM (1988) Relationship between the nephrotoxicity and ototoxicity induced by gentamicin in the guinea pig. Acta Oto-Laryngol 106:219–225. https://doi.org/10.3109/0001648880910642910.3109/00016488809106429 ↗
44. Posadowska U, Brzychczy-Włoch M, Drożdż A, Krok-Borkowicz M, Włodarczyk-Biegun M, Dobrzyński P, Chrzanowski W, Pamula E (2016) Injectable hybrid delivery system composed of gellan gum, nanoparticles and gentamicin for the localized treatment of bone infections. Expert Opin Drug Del 13:613–620. https://doi.org/10.1517/17425247.2016.114667310.1517/17425247.2016.1146673 ↗
45. Wang GH, Liu SJ, Ueng SWN, Chan EC (2004) The release of cefazolin and gentamicin from biodegradable PLA/PGA beads. Int J Pharmaceut 273:203–212. https://doi.org/10.1016/j.ijpharm.2004.01.01010.1016/j.ijpharm.2004.01.010 ↗
46. Fredenberg S, Wahlgren M, Reslow M et al (2011) The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review. Int J Pharmaceut 415:34–52. https://doi.org/10.1016/j.ijpharm.2011.05.04910.1016/j.ijpharm.2011.05.049 ↗
47. Gasmi H, Siepmann F, Hamoudi MC, Axelsson A (2016) Towards a better understanding of the different release phases from PLGA microparticles: dexamethasone-loaded systems. Int J Pharmaceut 514:189–199. https://doi.org/10.1016/j.ijpharm.2016.08.03210.1016/j.ijpharm.2016.08.032 ↗
48. Roth KE, Maier GS, Schmidtmann I, Eigner U, Huebner WD, Peters F, Drees P, Maus U (2019) Release of antibiotics out of a moldable collagen-beta-tricalciumphosphate-composite compared to two calcium phosphate granules. Materials 12:4056. https://doi.org/10.3390/ma1224405610.3390/ma12244056 ↗
49. Memar MY, Adibkia K, Farajnia S, Kafil HS, Dizaj SM, Ghotaslou R (2019) Biocompatibility, cytotoxicity and antimicrobial effects of gentamicin-loaded CaCO3 as a drug delivery to osteomyelitis. J Drug Deliv Sci Tec 54:101307. https://doi.org/10.1016/j.jddst.2019.10130710.1016/j.jddst.2019.101307 ↗
50. Choi CK, Kim H, Kwon H, Annable MD (2017) Effect of increased groundwater viscosity on the remedial performance of surfactant-enhanced air sparging. J Contam Hydrol 77:69–75. https://doi.org/10.1016/j.msec.2017.03.21510.1016/j.msec.2017.03.215 ↗
51. Zhao D, Zhu TT, Li J, Cui LG, Zhang ZY, Zhuang XL, Ding JX (2021) Poly(lactic-co-glycolic acid)-based composite bone-substitute materials. Bioact Mater 6:346–360. https://doi.org/10.1016/j.bioactmat.2020.08.01610.1016/j.bioactmat.2020.08.016 ↗
52. Szczeblinska J, Fijalkowski K, Kohn J, El Fray M (2017) Antibiotic loaded microspheres as antimicrobial delivery systems for medical applications. Mater Sci Eng C 77:69–75. https://doi.org/10.1016/j.msec.2017.03.21510.1016/j.msec.2017.03.215 ↗
53. Rostami F, Tamjid E, Behmanesh M (2020) Drug-eluting PCL/graphene oxide nanocomposite scaffolds for enhanced osteogenic differentiation of mesenchymal stem cells. Mater Sci Eng C 115:111102. https://doi.org/10.1016/j.msec.2020.11110210.1016/j.msec.2020.111102 ↗
54. Zennifer A, Senthilvelan P, Sethuraman S, Sundaramurthi D (2021) Key advances of carboxymethyl cellulose in tissue engineering and 3D bioprinting applications. Carbohyd Polym 256:117561. https://doi.org/10.1016/j.carbpol.2020.11756110.1016/j.carbpol.2020.117561 ↗
55. Chahal S, Hussain FSJ, Kumar A, Rasad MSBA, Yusoff MM (2016) Fabrication, characterization and in vitro biocompatibility of electrospun hydroxyethyl cellulose/poly (vinyl) alcohol nanofibrous composite biomaterial for bone tissue engineering. Chem Eng Sci 144:17–29. https://doi.org/10.1016/j.ces.2015.12.03010.1016/j.ces.2015.12.030 ↗